Get started
Author

Malak Tahsin

Observed names: M T Tahsin, Malak Ibrahim Tahsin
ORCID: 0000-0001-6299-6673
Observed ORCID: 0000-0001-6299-6673
OpenAlex ID: A5087685374
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression
2023 · José M. Rodriguez-Valadez, Malak Tahsin, et al. · Diabetes Care · 44
PDF
Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta‐Regression Analysis
2024 · José M. Rodriguez‐Valadez, Malak Tahsin, et al. · Journal of the American Heart Association · 21
PDF
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
2022 · Runpu Chen, Ian Pagano, et al. · Diagnostics · 4
PDF
Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis
2025 · R Ibrahim, M T Tahsin, et al. · European Heart Journal · 1
The Role of Multimodality Imaging in Guiding Ventricular Tachycardia Ablation: An Updated Review
2026 · Eiad Habib, Mahmoud Abdelnabi, et al. · Reviews in Cardiovascular Medicine
PDF
Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis
2025 · Ramzi Ibrahim, Robert Seby, et al. · Coronary Artery Disease
S2648 BB in the CBD! Retained Bullet After Abdominal Gunshot Wound
2024 · Anne Jarvis, Malak Tahsin, et al. · The American Journal of Gastroenterology
A Case of Rheumatoid Arthritis Induced Heart Failure With Preserved Ejection Fraction
2024 · Malak Tahsin, Brandon Walls, et al. · Journal of the American College of Cardiology
A Rare Case of Apixaban-induced Hypersensitivity Skin Rash in the Critical Care Unit
2024 · Abdul-Fatawu Osman, Blessing Eze, et al. · Journal of the American College of Cardiology
Plasma cfDNA role in detecting cardiovascular, metabolic and other diseases in a FIT+ population enrolled for a colorectal cancer screening program.
2023 · Mauro Scimia, Francesco Pepe, et al. · Journal of Clinical Oncology
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-Analysis, and Meta-Regression
2023 · José M. Rodriguez-Valadez, Malak Tahsin, et al.
PDF
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-Analysis, and Meta-Regression
2023 · José M. Rodriguez-Valadez, Malak Tahsin, et al.
Abstract P140: Potential Mediators for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis
2023 · Jose M Rodriguez Valadez, Malak Tahsin, et al. · Circulation
Works count: 13
Citation count: 70
H-index: 3
I10-index: 2
Year
Topic
Type